CBD-Intel was on point in its 2021 predictions. Much like the preceding year, we believed 2021 would largely be defined more by what did not happen than what did ...
If 2020 was the year in the waiting-room then 2021 was perhaps the year of the unfulfilled hype. As predicted, there was little movement in many of the major issues controlling the CBD market ...
The acquisition of Mellow by US cannabis and CBD investment firm Thought Leaders will position the UK-based CBD marketplace to open in the US and bolster its position in Asia ...
The US-based heat-not-burn (HnB) hemp company Omura will announce a new set of target country markets in the first quarter of 2022, starting with Switzerland as a bridge into Europe ...
One major CBD retailer says the US Postal Service’s decision to stop shipping CBD vaping products isn’t affecting his business at all – because he isn’t complying ...
There are incorrect reports that a proposed bill in Florida would regulate delta-8 THC products in the state. In fact the bill will place limitations on the sale of all hemp-derived products ...
Cannabis firms continued to expand their footprint through to the end of 2021, with the lucrative US market being the strategic focus of many acquisitions, covering retail chains and tech companies ...
The potential of psychedelics to treat a range of mental health conditions continues to attract increasing levels of funding for clinical trials as firms work towards bringing them into mainstream medical use ...
Nancy Mace, a first-term Republican Congresswoman from South Carolina, recently introduced a bill in the House of Representatives that would decriminalise cannabis at the federal level ...
Legal recreational cannabis in South Dakota will have to wait following the state Supreme Court’s controversial decision to invalidate Amendment A, a ballot initiative passed by voters a year ago ...
As the market for medical cannabis goes on growing, dispensaries continue to drive merger and acquisition activity in the US as multi-state operators invest millions of dollars in expanding their retail footprint ...
Rahul Gupta has been confirmed by the US Senate as director of National Drug Control Policy, while president Joe Biden intends to nominate Robert Califf as head of the US Food and Drug Administration (FDA)...
It owns one of North America’s biggest chains of convenience stores and fuel stations – now Alimentation Couche-Tard may have the potential to become one of its foremost providers of cannabis and CBD ...
The economic tide flowing for cannabis continues to float businesses in the US in secondary areas such as cultivation systems and delivery services too ...
US cannabis dispensaries are attracting significant interest from investors and several multi-million dollar deals have been agreed as operators expand their footprint into new states ...
Ambiguous messages about where CBD companies will ship to in the USA may result in risk-averse online payments processors refusing to deal with them, says a speakers at the upcoming USA-CBD Expo in Chicago ...
Interest in psychedelic drugs and treatments continues to grow, as evidenced by three major takeovers in Canada and the USA, two involving drug treatments developments and another offering a network of ketamine infusion treatment centres...
It turns out the Charlotte’s Web application to the US FDA for the registration of a full spectrum hemp extract as a new dietary ingredient (NDI) DID include data from the ValidCare industry study ...
The lack of a clear regulatory pathway to market for CBD products in the US is highlighted by a row over the FDA’s denial of new dietary ingredient (NDI) approval for full spectrum hemp extracts...
Two North American entrepreneurs have put millions of dollars into exploring the treatment efficacy of psychedelics, based on personal experience of using them to help deal with their own mental health issues ...
Patience continues to be the watchword when it comes to innovation in the cannabinoid beverage space. Developments continue but companies appear willing to take their time to enter the market as regulation loosens ...
Although many point to tax rates driving legal prices higher than those on the illicit market, access plays a bigger role than price in the survival of cannabis black markets, according to experts ...
Written by Lorraine Mullaney | 23rd September 2021
The US Drug Enforcement Agency (DEA) is calling for an increase in production of cannabis and psychedelics to supply federal research and clinical trials ...
Kentucky and Tennessee are among a large number of Southeastern US states that have not yet passed legislation for medical cannabis programs. Here, CBD-Intel examines the issues behind the official reluctance ...
Enforcement action against companies pushing the limits on marketing delta-8 THC products in the US is likely following a health advisory from the FDA and CDC ...
The US Food and Drug Administration (FDA) and Centers for Disease Control (CDC) have issued warnings about the rise of reported incidents in the US regarding the use of delta-8 THC ...
CBD products are not eligible for trademark protection, US regulators have reaffirmed, because they are not legal under the federal Food, Drug, and Cosmetic Act (FDCA) ...
NFL veteran Chris Hetherington has launched a CBD oil derived entirely from orange peel, describing it as “crystalline CBD at a purity and consistency difficult to match with cannabis or hemp-derived material” ...
Written by Lorraine Mullaney | 10th September 2021
A $545m deal to buy the company Gage Growth will give North American cannabis operator TerrAscend access to the cannabis market in the US state of Michigan ...
The makers of a new CBD pain relief cream – mixed with an actual local anaesthetic – are bullish about their prospects of a sales boost from an endorsement deal with one of the most...
CBD beverages continue to be a popular niche sub-category for producers, with brands still experimenting and bringing out new variations. Some significant regulatory concerns remain for the mid/long-term. Neither the US, UK or EU has...
A ban on the production and sale of smokable hemp products in Texas has been fully overturned after two court decisions – but the case will almost certainly head through two further levels of appeal...
Two-star Michelin expertise is coming to the US CBD sector with the advent of a new CBD beverage with flavours developed by British chef Michael Caines ...
There are now only 14 US states that have yet to implement a medical cannabis programme. Why they are behind the curve on the issue is something of a mystery ...
CBD pet products remain in a grey area in terms of both legality and effectiveness – but there have been some attempts in both to shed light into the darkness ...
Cult favourite Jones Soda will enter the US cannabis beverage market, while an Oklahoma firm’s new beverage launch looks well positioned to capitalise on any move to a recreational market in the state ...
A recent ring trial assessment of the lab performances and methods for measuring CBD in commercial products has given some good news to the industry ...
New methods for laboratory production of cannabinoids show some promise – but it’s still not clear whether they will yield enough to be commercially viable ...
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.